The expression of CD117 and CD44, which has been associated with a cancer stem cell phenotype in ovarian cancer, was found in up to 90% of EpCAM+/CD45+ ovarian cancer hybrid cells [138] indicating an association of cell fusion with the origin of cancer stem/initiating cells. The gene discussed is PTPRC; the disease is ovarian carcinoma.